Cart
sales@molnova.com
Ataquimast
CAS No. 182316-31-0
Ataquimast( —— )
Catalog No. M27960 CAS No. 182316-31-0
Ataquimast is used in curing advanced receptor-positive breast cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 302 | Get Quote |
|
| 10MG | 447 | Get Quote |
|
| 25MG | 714 | Get Quote |
|
| 50MG | 1017 | Get Quote |
|
| 100MG | 1368 | Get Quote |
|
| 500MG | 2673 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAtaquimast
-
NoteResearch use only, not for human use.
-
Brief DescriptionAtaquimast is used in curing advanced receptor-positive breast cancer.
-
DescriptionAtaquimast is used in curing advanced receptor-positive breast cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorGCN2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number182316-31-0
-
Formula Weight203.245
-
Molecular FormulaC11H13N3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCn1c2ccccc2nc(NC)c1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dieter Dorsch, et al. Triazolo[4,5-d]pyrimidine derivatives. WO2013110309A1.
molnova catalog
related products
-
Erucifolin N-oxide
Erucifolin N-oxide Description.
-
Tlatlancuayin
The herbs of Iresine herbstii.
-
Euchrestaflavanone B
Euchrestaflavanone B shows antibacterial activity against Gram positive bacteria, Staphylococcus aureus, Bacillus subtilis and Bacillus cereus. Euchrestaflavanone B may function by inhibiting oncogenic disease, at least in part, through the inhibition of protein kinase CKII activity.
